Gastrin-releasing peptide, immune responses, and lung disease

Annals of the New York Academy of Sciences

Volumn 1144, Issue , 2008, Pages 136-147

  Degan, Simone ^a   Lopez, Giselle Y ^a   Kevill, Katharine ^a   Sunday, Mary E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveolarization; Autoimmunity; Bombesin; Bronchopulmonary dysplasia; Endothelial cells; Gastrin releasing peptide; Mast cells; Thymic nurse cells

Indexed keywords

BOMBESIN; GASTRIN RELEASING PEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

BABOON; CELL HYPERPLASIA; CHRONIC LUNG DISEASE; CONFERENCE PAPER; EARLY DIAGNOSIS; FETUS; FETUS LUNG; GASTRIN RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LUNG DISEASE; LUNG DYSPLASIA; NEUROSECRETORY CELL; NONHUMAN; PREMATURITY; RESPIRATORY DISTRESS;

ANIMALIA;

EID: 56649103857     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1418.022     Document Type: Conference Paper

References (140)

1. Erspamer, V. 1988. Discovery, isolation, and characterization of bombesin-like peptides. Ann. N Y Acad. Sci. 547 : 3 9.
2. Spindel, E.R. et al. 1984. Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc. Natl. Acad. Sci. USA 81 : 5699 5703.
3. Sunday, M.E., et al. 1988. Biology of disease: gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab. Invest. 59 : 5 24.
4. Wharton, J. et al. 1978. Bombesin-like immunoreactivity in the lung. Nature 273 : 769 770.
5. Siegfried, J.M., P.J. Guentert & A.L. Gaither. 1993. Effects of bombesin and gastrin-releasing peptide on human bronchial epithelial cells from a series of donors: individual variation and modulation by bombesin analogs. Anat. Rec. 236 : 241 247.
6. Rozengurt, E. & J. Sinnett-Smith. 1988. Early signals underlying the induction of the c-fos and c-myc genes in quiescent fibroblasts: studies with bombesin and other growth factors. Prog. Nucleic Acid Res. Mol. Biol. 35 : 261 295.
7. Cuttitta, F. et al. 1985. Bombesin-like peptides can function as autocrine growth factors in human small cell cancer. Nature 316 : 823 826.
8. Impicciatore, M. & G. Bertaccini. 1973. The bronchoconstrictor action of the tetradecapeptide bombesin in the guinea-pig. J. Pharm. Pharmacol. 25 : 872 875.
9. Sunday, M.E. et al. 1993. Anti-bombesin antibodies modulate fetal mouse lung growth and maturation in utero and in organ cultures. Anat. Rec. 236 : 25 32.
10. Sunday, M.E. et al. 1990. Bombesin increases fetal lung growth and maturation in utero and in organ culture. Am. J. Respir. Cell Mol. Biol. 3 : 199 205.
11. Kim, J.S., V.S. McKinnis & S.R. White. 1997. Migration of guinea pig airway epithelial cells in response to bombesin analogues. Am. J. Respir. Cell Mol. Biol. 16 : 259 266.
12. Meloni, F. et al. 1996. Bombesin enhances monocyte and macrophage activities: possible role in the modulation of local pulmonary defenses in chronic bronchitis. Respiration 63 : 28 34.
13. Yule, K.A. & S.R. White. 1999. Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin. Exp. Lung Res. 25 : 261 273.
14. Ruff, M., E. Schiffmann, V. Terranova & C.B. Pert. 1985. Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin. Immunol. Immunopathol. 37 : 387 396.
15. Meloni, F. et al. 1995. In vitro effect of bombesin-related peptides on the procoagulant activity of alveolar macrophages. Monaldi Arch. Chest Dis. 50 : 187 190.
16. Gonzalez, N. et al. 2008. Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr. Opin Endocrinol. Diabetes Obes. 15 : 58 64.
17. Battey, J.F. et al. 1991. Molecular cloning of the bombesin/gastrin- releasing peptide receptor from Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 88 : 395 399.
18. Spindel, E.R. et al. 1990. Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol. Endocrinol. 4 : 1956 1963.
19. Lach, E., E.B. Haddad & J.P. Gies. 1993. Contractile effect of bombesin on guinea pig lung in vitro: involvement of gastrin-releasing peptide-preferring receptors. Am. J. Physiol. 264 : L80 L86.
20. Wada, E. et al. 1991. cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron 6 : 421 430.
21. Fathi, Z. et al. 1993. BRS-3: A novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J. Biol. Chem. 268 : 5979 5984.
22. Gorbulev, V., A. Akhundova, H. Buchner & F. Fahrenholz. 1992. Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. Eur. J. Biochem. 208 : 405 410.
23. Emanuel, R.L. et al. 1999. Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation. Am. J. Physiol. 277 : L1003 L1017.
24. Fischer, J.B. & A. Schonbrunn. 1988. The bombesin receptor is coupled to a guanine nucleotide-binding protein which is insensitive to pertussis and cholera toxins. J. Biol. Chem. 263 : 2808 2816.
25. Zachary, I. et al. 1991. Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation in intact Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 88 : 4577 4581.
26. Rozengurt, E. 1991. Neuropeptides as cellular growth factors: role of multiple signalling pathways. Eur. J. Clin. Invest. 21 : 123 134.
27. King, K.A. et al. 1993. CD10/neutral endopeptidase regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J. Clin. Invest. 91 : 1969 1973.
28. Spindel, E.R. et al. 1987. Transient elevation of mRNAs encoding gastrin-releasing peptide (GRP), a putative pulmonary growth factor, in human fetal lung. J. Clin. Invest. 80 : 1172 1179.
29. King, K.A., J.S. Torday & M.E. Sunday. 1995. Bombesin and [leu8]phyllolitorin promote fetal mouse lung branching morphogenesis via a specific receptor-mediated mechanism. Proc. Natl. Acad. Sci. USA 92 : 4357 4361.
30. Sunday, M.E. et al. 1992. CD10/neutral endopeptidase 24.11 in developing human fetal lung: patterns of expression and modulation of peptide-mediated proliferation. J. Clin. Invest. 90 : 2517 2525.
31. Fraslon, C. & J.R. Bourbon. 1992. Comparison of effects of epidermal and insulin-like growth factors, gastrin releasing peptide and retinoic acid on fetal lung cell growth and maturation in vitro. Biochim. Biophys. Acta 1123 : 65 75.
32. Kelley, M.J. et al. 1997. Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest 112 : 256 261.
33. Wang, L.H. et al. 1990. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. Biochemistry 29 : 616 622.
34. Wang, L.H. et al. 1990. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. J. Biol. Chem. 265 : 15695 15703.
35. Youngson, C., C. Nurse, H. Yeger & E. Cutz. 1993. Oxygen sensing in airway chemoreceptors. Nature 365 : 153 155.
36. Cutz, E., H. Yeger & J. Pan. 2007. Pulmonary neuroendocrine cell system in pediatric lung disease-recent advances. Pediatr. Dev. Pathol. 10 : 419 435.
37. Johnson, D.E., J.E. Lock, R.P. Elde & T.R. Thompson. 1982. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia. Pediatr. Res. 16 : 446 454.
38. Johnson, D.E., W.R. Anderson & B.A. Burke. 1993. Pulmonary neuroendocrine cells in pediatric lung disease: alterations in airway structure in infants with bronchopulmonary dysplasia. Anat. Rec. 236 : 115 119.
39. Aguayo, S.M. et al. 1989. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J. Clin. Invest. 84 : 1105 1113.
40. Aguayo, S. et al. 1992. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases. Cancer Res. (Suppl.) 52 : 2727s 2731s.
41. Aguayo, S.M. et al. 1990. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J. Clin. Invest. 86 : 838 844.
42. Aguayo, S.M. 1993. Pulmonary neuroendocrine cells in tobacco-related lung disorders. Anat. Rec. 236 : 122 127.
43. Nickerson, B.G. & L.M. Taussig. 1980. Family history of asthma in infants with bronchopulmonary dysplasia. Pediatrics 65 : 1140 1144.
44. Antonucci, R. et al. 2004. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia? J. Perinat. Med. 32 : 272 277.
45. Halvorsen, T. et al. 2005. Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr. Allergy Immunol. 16 : 487 494.
46. Weitzman, M., S. Gortmaker, D.K. Walker & A. Sobol. 1990. Maternal smoking and childhood asthma. Pediatrics 85 : 505 511.
47. Martinez, F.D., M. Cline & B. Burrows. 1992. Increased incidence of asthma in children of smoking mothers. Pediatrics 89 : 21 26.
48. Hanrahan, J.P. et al. 1992. The effect of maternal smoking during pregnancy on early infant lung function. Am. Rev. Respir. Dis. 145 : 1129 1135.
49. Hoff, C. et al. 1986. Trend associations of smoking with maternal, fetal and neonatal morbidity. Obstet. Gynecol. 68 : 317 321.
50. Chen, M.F., G. Kimizuka & N.S. Wang. 1987. Human fetal lung changes associated with maternal smoking during pregnancy. Pediatr. Pulmonol. 3 : 51 58.
51. Chen, M.F. et al. 1991. Gastrin-releasing peptide gene products in midtrimester human fetal lung with and without maternal smoking history during pregnancy. Pediatr. Pulmonol. 10 : 30 35.
52. Sunday, M.E. & C.G. Willett. 1992. Induction and spontaneous regression of intense pulmonary neuroendocrine cell differentiation in a model of preneoplastic lung injury. Cancer Res. 52 (Suppl. 2677s 2686s.
53. Bousbaa, H., F. Poron & J. Fleury-Feith. 1994. Changes in chromogranin A-immunoreactive guinea-pig pulmonary neuroendocrine cells after sensitization and challenge with ovalbumin. Cell Tissue Res. 275 : 195 199.
54. Tsukiji, J. et al. 2004. Long-term induction of beta-CGRP mRNA in rat lungs by allergic inflammation. Life Sci. 76 : 163 177.
55. Northway, W.H., R.C. Rosan & D.Y. Porter. 1967. Pulmonary disease following respirator therapy of hyaline membrane disease. N. Engl. J. Med. 276 : 357 368.
56. Hansen, T. & A. Corbet. 1991. Chronic lung disease - Bronchopulmonary dysplasia. In Diseases of the Newborn, H.W. Taeusch, R.A. Ballard & M.E. Avery, Eds. : 519 526, W.B. Saunders Co. Toronto, Canada.
57. Ikegami, M. & A.H. Jobe. 2002. Postnatal lung inflammation increased by ventilation of preterm lambs exposed antenatally to Escherichia coli endotoxin. Pediatr. Res. 52 : 356 362.
58. Coalson, J.J. 2006. Pathology of bronchopulmonary dysplasia. Semin. Perinatol. 30 : 179 184.
59. Baraldi, E. & M. Filippone. 2007. Chronic lung disease after premature birth. N. Engl. J. Med. 357 : 1946 155.
60. Bhandari, A. & H.B. Panitch. 2006. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol. 30 : 219 226.
61. Abman, H. & J.R. Groothius. 1994. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr. Clin. N. Am. 41 : 277 315.
62. Ireys, H.T., G.F. Anderson, T.J. Shaffer & J.M. Neff. 1997. Expenditures for care of children with chronic illnesses enrolled in the Washington state Medicaid program, fiscal year 1993. Pediatrics 100 : 197 204.
63. Jobe, A.H. & E. Bancalari. 2001. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163 : 1723 1729.
64. Jobe, A.H., B.R. Mitchell & H. Gunkel. 1993. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am. J. Obstet. Gynecol. 168 : 508 513.
65. Jobe, A.H. 2003. Antenatal factors and the development of bronchopulmonary dysplasia. Semin. Neonatol. 8 : 9 17.
66. Parker, R.A., D.P. Lindstrom & R.B. Cotton. 1992. Improved survival accounts for most, but not all of the increase in bronchopulmonary dysplasia. Pediatrics 90 : 663 668.
67. Avery, M.E. et al. 1987. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79 : 26 30.
68. Watterberg, K.L., L.M. Derners, S.M. Scott & S. Murphy. 1996. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97 : 210 215.
69. Konishi, M. et al. 1988. Surfactant replacement therapy in neonatal respiratory distress syndrome. Eur. J. Pharmacol. 147 : 20 25.
70. Parker, R.A., D.P. Lindstrom & R.B. Cotton. 1996. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin. Perinatol. 20 : 206 209.
71. Evans, M. et al. 1998. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. Am. J. Epidemiol. 148 : 460 466.
72. Feinberg, E. et al. 1997. Late pulmonary outcomes poorly predicted by early risk factors in very low birth weight infants. Pediatr. Res. 39 : 263A.
73. Escobedo, M.B. et al. 1982. A baboon model of bronchopulmonary dysplasia: I. Clinical features. Exp. Mol. Pathol. 37 : 323 334.
74. Coalson, J.J. et al. 1982. A baboon model of bronchopulmonary dysplasia: II. Pathologic features. Exp. Mol. Pathol. 37 : 335 350.
75. Coalson, J.J., V.T. Winter, T. Siler-Khodr & B.A. Yoder. 1999. Neonatal chronic lung disease in extremely immature baboons. Am. J. Respir. Crit. Care Med. 160 : 1333 1346.
76. Northway, W.H. 1992. Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 89 : 969 973.
77. Sunday, M.E., B.A. Yoder, F. Cuttitta, et al. 1998. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J. Clin. Invest. 102 : 584 594.
78. Subramaniam, M. et al. 2007. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 176 : 902 912.
79. Cullen, A. et al. 2002. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 165 : 1093 1097.
80. Avis, I.L. et al. 1991. Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small cell lung cancer. J. Natl. Cancer Inst. 83 : 1470 1476.
81. Chaudhry, A. et al. 1999. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin. Cancer Res. 5 : 3385 3393.
82. Galli, S.J. et al. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23 : 749 786.
83. Takahashi, H., H. Sano, H. Chiba & Y. Kuroki. 2006. Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases. Curr. Pharm. Des. 12 : 589 598.
84. Pastva, A.M., J.R. Wright & K.L. Williams. 2007. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc. Am. Thorac. Soc. 4 : 252 257.
85. Novak, N. & T. Bieber. 2008. 2. Dendritic cells as regulators of immunity and tolerance. J. Allergy Clin. Immunol. 121, S370 S374 quiz S413.
86. Jacobs, B. et al. 2008. Dendritic cell subtypes and in vitro generation of dendritic cells. Horm. Metab. Res. 40 : 99 107.
87. Jobe, A.H. & M. Ikegami. 1998. Mechanisms initiating lung injury in the preterm. Early Hum. Dev. 53 : 81 94.
88. Kaminski, N. et al. 2000. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc. Natl. Acad. Sci.USA 97 : 1778 1783.
89. Nelson, S. & W.R. Summer. 1998. Innate immunity, cytokines, and pulmonary host defense. [Review]. Infect. Dis. Clin. N. Am. 12 : 555 567.
90. Raghavender, B. & J.B. Smith. 1997. Eosinophil cationic protein in tracheal aspirates of preterm infants with bronchopulmonary dysplasia. J. Pediatr. 130 : 944 947.
91. Lyle, R.E., A.F. Tryka, W.S. Griffin & B.J. Taylor. 1995. Tryptase immunoreactive mast cell hyperplasia in bronchopulmonary dysplasia. Pediatr. Pulmonol. 19 : 336 343.
92. Inoue, Y. et al. 1996. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am. J. Pathol. 149 : 2037 2054.
93. Galli, S.J., M. Maurer & C.S. Lantz. 1999. Mast cells as sentinels of innate immunity. [Review]. Curr. Opin. Immunol. 11 : 53 59.
94. Dvorak, A.M. 1997. New aspects of mast cell biology. Int. Arch. Allergy Immunol. 114 : 1 9.
95. Del Rio, M., A. Hernanz & M. De la Fuente. 1994. Bombesin, gastrin-releasing peptide, and neuromedin C modulate murine lymphocyte proliferation through adherent accessory cells and activate protein kinase C. Peptides 15 : 15 22.
96. Marion-Audibert, A.M. et al. 2000. [Effects of endocrine peptides on proliferation, migration and differentiation of human endothelial cells]. [French]. Gastroenterol. Clin.Biol. 24 : 644 648.
97. Strieter, R.M., J.A. Belperio & M.P. Keane. 2002. Cytokines in innate host defense in the lung. J. Clin. Invest. 109 : 699 705.
98. Speer, C.P. 2006. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin. Fetal Neonatal. Med. 11 : 354 362. Epub 2006 May 15.
99. Munshi, U.K., J.O. Niu, M.M. Siddiq & L.A. Parton. 1997. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr. Pulmonol. 24 : 331 336.
100. Brusselle, G.G. et al. 1994. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy 24 : 73 80.
101. Schwarze, J. et al. 1999. IL-5 and eosinophils are essential for the development of airway hyperrresponsiveness following acute respiratory syncytial virus infection. J. Immunol. 162 : 2997 3004.
102. Viola, J.P., A. Kiani, P.T. Bozza & A. Rao. 1998. Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: role of interleukin-4 (IL-4) and IL-5. Blood 91 : 2223 2230.
103. Temann, U.A., G.P. Geba, J.A. Rankin & R.A. Flavell. 1998. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188 : 1307 1320.
104. Mould, A.W. et al. 2000. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. J. Immunol. 164 : 2142 2150.
105. Zhu, Z. et al. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103 : 779 788.
106. Lee, J.J. et al. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185 : 2143 2156.
107. Bozic, C.R. et al. 1996. Neurogenic amplification of immune complex inflammation. Science 273 : 1722 1725.
108. Hopken, U.E., B. Lu, N.P. Gerard & C. Gerard. 1997. Impaired inflammation responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186 : 749 756.
109. Broide, D.H., K. Campbell, T. Gifford & P. Sriramarao. 2000. Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium. Blood 95 : 263 269.
110. Pryhuber, G.S. et al. 2000. Ablation of tumor necrosis factor receptor type 1 (p55) alters oxygen-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 278 : L1082 L1090.
111. Ward, N.S. et al. 2000. Interleukin-6 induced protection in hyperoxic acute lung injury. Am. J. Respir. Cell Mol. Biol. 22 : 535 542.
112. Yang, X., S. Wang, Y. Fan & X. Han. 2000. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur. J. Immunol. 30 : 382 391.
113. Waxman, A.B. et al. 1998. Targeted lung expression of inteleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J. Clin. Invest. 101 : 1970 1982.
114. Zhang, J. et al. 1999. Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: further evidence that proteolytically-active tryptase is a potent fibrogenic factor. J. Cell Physiol. 181 : 312 318.
115. Makarenkova, V.P. et al. 2003. Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells. J. Neuroimmunol. 145 : 55 67.
116. Sang, Q.X. 1998. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 8 : 171 177.
117. Majno, G. 1998. Chronic inflammation. Links with angiogenesis and wound healing. Am. J. Pathol. 153 : 1035 1039.
118. Rozengurt, E. & J. Sinnett-Smith. 1990. Bombesin stimulation of fibroblast mitogenesis: specific receptors, signal transduction and early events. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 327 : 209 221.
119. Toti, P. et al. 1997. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr. Pulmonol. 24 : 22 28.
120. Sun, G. et al. 1997. Endothelin-1 induces bronchial myofibroblast differentiation. Peptides 18 : 1449 1451.
121. Zetter, B.R. 1998. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49 : 407 424.
122. Fredenburgh, L.E. et al. 2005. Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels. Cell Mol. Biol. (Noisy-Le-Grand) 51 : 513 520.
123. Choi, A.M.K. & J. Alam. 1996. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15 : 9 19.
124. Christou, H. et al. 2000. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ. Res. 86 : 1224 1229.
125. Chang, L. et al. 2003. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am. J. Respir. Cell Mol. Biol. 167 : 57 64.
126. Contreras, M. et al. 1996. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit. Care Med. 24 : 29 37.
127. Abbas, A.K., A.H. Lichtman & S. Pillai. 2007. Cellular and Molecular Immunology. Elsevier. Philadelphia.
128. Rosen, D.M. et al. 2006. Accelerated thymic maturation and autoreactive T-cells in bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 174 : 75 83.
129. Guyden, J.C. & M. Pezzano. 2003. Thymic nurse cells: a microenvironment for thymocyte development and selection. Int. Rev. Cytol. 223 : 1 37.
130. Steinman, R.M. & M.C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci.USA 99 : 351 358.
131. De Felice, C. et al. (2002. Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. Pediatrics 110 : 386 388.
132. Peleg, L. & M.N. Nesbitt. 1984. Genetic control of thymus size in inbred mice. J. Hered. 75 : 126 130.
133. Hasselbalch, H. et al. 1997. Thymus size evaluated by sonography. A longitudinal study on infants during the first year of life. Acta Radiol. 38 : 222 227.
134. De Leeuw, F.E. et al. 1992. The neural and neuro-endocrine component of the human thymus. I. Nerve-like structure. Brain Behav. Immun. 6 : 234 248.
135. Steinman, R.M., D. Hawiger & M.C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 : 685 711.
136. Brelinska, R., A. Paczkowska, K. Kowalska & J. Jaroszewski. 2002. Lympho-epithelial interactions in rat thymus during pregnancy. Folia Histochem. Cytobiol. 40 : 175 176.
137. Jones, G.V., C.A. Botham, A.G. Clarke & M.D. Kendall. 1998. Immunoreactivity of neural crest-derived cells in thymic tissue developing under the rat kidney capsule. Brain Behav. Immun. 12 : 163 180.
138. Martin-Fontecha, A. et al. 1993. The neuro-endocrine component of the rat thymus: studies on cultured thymic fragments before and after transplantation in congenitally athymic and euthymic rats. Brain Behav. Immun. 7 : 1 15.
139. Chen, C.M. et al. 2000. Thymus size and its relationship to perinatal events. Acta Paediatr. 89 : 975 978.
140. Dal-Pizzol, F. et al. 2006. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am. J. Respir. Crit. Care Med. 173 : 84 90. Epub 2005 Sep 28.